WASHINGTON, June 21 The U.S. Supreme Court said
on Monday it rejected an appeal by Pfizer Inc (PFE.N) of a
ruling that ordered a retrial on how much punitive damages
should be awarded to a woman who developed breast cancer after
taking the company's hormone replacement therapy drugs.
Pfizer in its appeal argued that a retrial limited to just
punitive damages violated its jury trial rights protected by
the Constitution, and that the trial judge in the case had
improperly admitted the testimony of a scientific expert.
A jury in Arkansas in 2008 sided with Donna Scroggin in her
lawsuit against two Pfizer units -- Wyeth and Upjohn. She was
diagnosed with breast cancer in 2000, after taking hormone
replacement therapy drugs for 11 years.
(Reporting by James Vicini, Editing by Maureen Bavdek)